Hero Banner
Wednesday, October 18
Pre-Conference: The Role of Digital Health & Technology in Cardiometabolic Risk Reduction: Where We Are and Where Are We Going
12:00 PM — 12:05 PM
Opening Remarks
Chair: Seth Martin, MD, MHS
12:05 PM — 12:25 PM
Setting the Stage: What Digital Health Means for Clinicians and Patients
Technology & Digital Health in Lifestyle and Obesity
12:25 PM – 12:45 PM
Health and Care Apps for Lifestyle and Obesity: The Importance of Self-Monitoring
12:45 PM – 1:05 PM
Continuous Glucose Monitoring: The New Frontier in Lifestyle Management?
Athena Philis-Tsimikas, MD
1:05 PM – 1:25 PM
Changing Behavior Using Digital Health for Long Term Weight Management
Martin S. Hagger, PhD
Technology & Digital Health in Type 2 Diabetes
1:25 PM – 1:45 PM
The Role of CGM in the Management of Type 2 Diabetes: Patient Selection & Important Pearls
Grazia Aleppo, MD, FACE, FACP
1:45 PM – 2:05 PM
Insulin Delivery and Insulin Pumps in Patients with Type 2 Diabetes
Viral S. Shah, MD
2:05 PM – 2:25 PM
Glucose-responsive Insulin Delivery and Closed Loop Systems: The Current State & What the Future Holds
2:25 PM – 2:55 PM
Refresh and Recharge Break
2:55 PM – 3:55 PM
Primetime CME Symposium
Technology & Digital Health in CVD & CVD Risk Reduction
3:55 PM – 4:15 PM
Technology to Close Gaps in Hypertension Care
Daichi Shimbo, MD
4:15 PM – 4:35 PM
Advances in Digital Health for Arrhythmia Management
4:35 PM – 4:55 PM
Health Technologies for CVD Prevention
Technology & Digital Health in Cardiometabolic Health: Discussions & Practical Strategies for Implementation
4:55 PM – 5:15 PM
Discussions & Perspectives: What Role Does Technology and Digital Health Play in Addressing Disparities in Care?
Moderator: Seth Martin, MD, MHS
Panelists: Yvonne Commodore-Mensah, PhD, MHS, RN
5:15 PM – 5:45 PM
How Do Clinicians and Patients Better Use This Data: Challenges and Possible Solutions
Moderator: Seth Martin, MD, MHS
Panelists: Eric D. Peterson, MD, MPH
5:45 PM – 6:15 PM
Refresh and Recharge Break
6:15 PM – 6:45 PM
Fireside Chat: How Industry and Academic Medicine Can Work Together (Non-CME)
6:45 PM – 7:15 PM
Fireside Chat: What Would the World of Cardiometabolic Care Look Like If We Have Successful Academic and Industry Collaborations? (Non-CME)
Thursday, October 19
FDA Updates and Keynote
7:00 AM – 7:45 AM
PME Breakfast Symposium (non-CME)
Sponsored by AstraZeneca.
7:45 AM – 8:15 AM
Refresh and Recharge Break
8:15 AM – 10:15 AM
Opening Remarks & FDA Update and Late Breaking Trials
Moderator: Christie M. Ballantyne, MD
Presenters: Deepak L. Bhatt, MD; Robert H. Eckel, MD; Keith C. Ferdinand; Anne L. Peters, MD
10:15 AM – 10:45 AM
Keynote Address
Screening for Social Determinants of Cardiometabolic Health & Practice Implications
10:45 AM – 11:15 AM
Exhibit Hall Break
11:15 AM – 12:15 PM
PME Lunch Symposium (non-CME)
Sponsored by Novo Nordisk
Session I: Obesity & Lifestyle
12:15 PM – 12:45 PM
Exhibit Hall Break
12:45 PM – 12:45 PM
Opening Remarks
Robert H. Eckel, MD
12:45 PM– 1:45 PM
Diving Deeper Into Exercise Regimens for Cardiometabolic Health
1:45 PM– 2:45 PM
Debate and Discussion: Is it Time to Compare High-Intensity Pharmacotherapy to Surgery for the Management of Obesity?
Donna H. Ryan, MD; Christopher D. Still, DO
2:45 PM – 3:15 PM
Exhibit Hall Break
3:15 PM – 3:35 PM
The Intersection of Sleep and Cardiometabolic Risk: Important Connections and Practice Implications
Sirimon Reutrakul, MD
3:35 PM – 4:35 PM
Primetime CME Symposium
4:35 PM – 5:30 PM
Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Donna H. Ryan, MD; Sirimon Reutrakul, MD; Christopher D. Still, DO
5:30 PM – 6:30 PM
Welcome Reception
6:30 PM – 7:30 PM
Dinner Symposium
Friday, October 20
7:00 AM – 8:00 AM
Breakfast Symposium
Session II: Dyslipidemia/Atherosclerosis/Thrombosis
8:00 AM – 8:05 AM
Opening Remarks
Christie M. Ballantyne, MD
8:05 AM – 8:25 AM
Lp(a): The Assessment of Risk in the Absence of Clinical Trial Data
Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC
8:25 AM – 8:45 AM
Statin Intolerance: How To Assess and Practical Pearls for Addressing It
8:45 AM – 9:05 AM
Hypertriglyceridemia: Trials, Tribulations, and Transition to Clinical Practice
Michael D. Shapiro, DO
9:05 AM – 10:05 AM
Primetime CME Symposium
10:05 AM – 10:25 AM
Non-Statin Therapies for LDL-C Lowering: Making Sense of Recent Data and Recommendations
Pamela B. Morris, MD
10:25 AM – 11:25 AM
Challenging Lipid Management Cases & Panel Discussion
Moderator: Christie M. Ballantyne, MD
Panelists: Erin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC; Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC; Pamela B. Morris, MD; Michael D. Shapiro, DO
11:25 AM – 11:55 AM
Exhibit Hall Break
11:55 AM – 12:55 PM
PME Lunch Symposium (non-CME)
Sponsored by Ionis Pharmaceuticals, Inc.
12:55 PM – 1:25 PM
Exhibit Hall Break
Session III: Diabetes
1:25 PM – 1:25 PM
Opening Remarks
Anne L. Peters, MD
1:25 PM – 1:45 PM
Have We Forgotten About Glycemic Management in Type 2 Diabetes? Or Where Are We With Respect to Glycemic Control in T2D – A 2023 update
1:45 PM – 2:10 PM
Early Treatment Intensification in Type 2 Diabetes
Juan P. Frias, MD
2:10 PM – 3:10 PM
Primetime CME Symposium
3:10 PM – 3:40 PM
Exhibit Hall Break
3:40 PM – 4:00 PM
Optimizing Glycemic Control With Commonly-Available Combination Therapies: Tips and Pearls
Athena Philis-Tsimikas, MD
4:00 PM – 4:20 PM
How Social Determinants of Health Impact Type 2 Diabetes Treatment
4:20 PM – 5:20 PM
Challenging Diabetes Management Cases & Panel Discussion
Moderator: Anne L. Peters, MD
Panelists: Juan P. Frias, MD; Athena Philis-Tsimikas, MD
5:20 PM – 6:20 PM
Happy Hour & Giveaways
6:20 PM – 7:20 PM
Dinner Symposium
Saturday, October 21
Session IV: CardioRenal
7:00 AM – 8:00 AM
PME Breakfast Symposium (non-CME)
Sponsored by VeroScience.
8:00 AM – 8:00 AM
Opening Remarks
Keith C. Ferdinand, MD
8:00 AM – 8:35 AM
Be Careful What You Believe: Lessons From Clinical Trial Data
Keith C. Ferdinand, MD
8:35 AM – 9:05 AM
Resistant Hypertension: Definitions, Current Treatment and Emerging Approaches
Debbie Cohen, MD
9:05 AM – 9:35 AM
Sleep and Hypertension: A Two-Way Street
Virend K. Somers, MD, PhD
9:35 AM – 9:50 AM
Refresh and Recharge Break
9:50 AM – 10:50 AM
Primetime Symposium
10:50 AM – 11:20 AM
The Role of Steroidal and Non-steroidal MRAs in Cardiorenal Risk Reduction
Ajay K. Singh, MBBS, FRCP, MBA
11:20 AM – 11:40 AM
Which Patients Should Get SGLT2is and GLP-1 RAs for cardiorenal risk reduction? Interpreting Guidelines and Clinical Trials to Patient Care
11:40 AM – 12:00 PM
The Continuum of Heart Failure
12:00 PM – 1:00 PM
Challenging Cardiorenal Cases & Expert Panel Discussion
Moderator: Keith C. Ferdinand, MD
Panelists: Debbie Cohen, MD; Ajay K. Singh, MBBS, FRCP, MBA; Virend K. Somers, MD, PhD